Company intelligence / Profile preview

Dispatch Biotherapeutics

Cambridge, MA, USAdispatchbiotx.com ↗
Ownership
Private
Development stage
Other
01

Overview

Dispatch Biotherapeutics is a biotechnology company dedicated to engineering precision-targeted immunotherapies for the treatment of solid tumors. Utilizing its proprietary Dispatch platform, the company develops bispecific fusion proteins designed to deliver potent cytokines, such as Interleukin-12 and Interleukin-15, directly to the tumor microenvironment. This spatial targeting strategy aims to maximize local immune activation while avoiding the severe systemic toxicities that have historically limited cytokine therapies. Founded and incubated by MPM Capital, Dispatch Biotherapeutics is advancing a pipeline of programs intended to transform the landscape of cancer treatment through localized immune modulation.

Therapeutic areas
Oncology
Modalities
Recombinant fusion proteinCytokineBispecific monoclonal antibody
Industry
Biotech
02

Drug pipeline

2 assets

DISP-40

Preclinical

1 more asset in the full pipeline.

Beyond the preview

Go deeper on Dispatch Biotherapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dispatch Biotherapeutics.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call